Copyright
©2011 Baishideng Publishing Group Co.
World J Clin Oncol. Aug 10, 2011; 2(8): 303-310
Published online Aug 10, 2011. doi: 10.5306/wjco.v2.i8.303
Published online Aug 10, 2011. doi: 10.5306/wjco.v2.i8.303
Figure 6 Kaplan-Meier estimates of probabilities of progression-free survival in patients with metastatic breast cancer who had less than 5 circulating tumor cells and those who had 5 or more circulating tumor cells (at the first follow-up visit after initiation of a new line of therapy)[29].
CTC: Circulating tumor cell.
- Citation: Park Y, Kitahara T, Urita T, Yoshida Y, Kato R. Expected clinical applications of circulating tumor cells in breast cancer. World J Clin Oncol 2011; 2(8): 303-310
- URL: https://www.wjgnet.com/2218-4333/full/v2/i8/303.htm
- DOI: https://dx.doi.org/10.5306/wjco.v2.i8.303